# novartis-financial-analysis
This repository contains a comprehensive financial analysis of Novartis from 2019 to 2023, benchmarked against AstraZeneca and Roche. Conducted as part of the Accounting, Finance &amp; Control course, the study evaluates profitability, liquidity, R&amp;D strategy, and market positioning using key financial metrics.
